Ketalar and hepatotoxicity 
Ketalar and hepatotoxicity Patient Reports February 13, 2012
Ketalar Side Effects Report #5505561-7
Ketalar side effect was reported by a Pharmacist from UNITED KINGDOM on Oct 23, 2007. Female patient, weighting 136.7 lb, was diagnosed with pain
and was treated with Ketalar. After drug was administered, patient experienced the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease. Ketalar dosage: TEXT:4 MG/ML-FREQ:1-6 ML/HOUR INFUSION. During the same period patient was treated with NORETHISTERONELET, VORICONAZOLE, ACETAMINOPHEN, CASPOFUNGIN, CYCLOSPORINE, ONDANSETRON, CHLORPHENIRAMINE MALEATE, OMEPRAZOLE. Patient recovered.Ketalar Side Effects Report #5573813-0
Ketalar side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 14, 2007. Female patient, weighting 136.7 lb, was diagnosed with pain
and was treated with Ketalar. After drug was administered, patient experienced the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease. Ketalar dosage: TEXT:4 MG/ML-FREQ:1-6 ML/HOUR INFUSION. During the same period patient was treated with NORETHISTERONELET, VORICONAZOLE, PARACETAMOL, CASPOFUNGIN, CYCLOSPORINE, ONDANSETRON, CHLORPHENAMINE, OMEPRAZOLE. Patient recovered.